专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20160137844A1 CARBAZOLE DIOXAZINE PIGMENT AND A METHOD FOR ITS PREPARATION 审中-公开
标题翻译：卡巴唑二氧杂环己烷色素及其制备方法
公开(公告)号：US20160137844A1
公开(公告)日：2016-05-19
申请号：US14896876
申请日：2014-06-11
申请人： Keki Hormusji GHARDA
发明人： Keki Hormusji GHARDA
IPC分类号： C09B19/02
CPC分类号： C09B19/02 , C09D11/037 , C09D11/322
摘要： The present disclosure provides carbazole-dioxazine pigment of Formula I; wherein, R is C1-C8 alkyl group, preferably R is an ethyl group, R1 is a chloro group, and R2 is a —NHC(═O)Ph group. The pigment is synthesized from 3-nitro-N-ethylcarbazole. The first step is nitration of 3-nitro-N-ethylcarbazole to form 3,6-dinitro-N-ethylcarbazole which is reduced to form 3-amino-6-nitro-N-ethylcarbazole. This amino compound is benzoylated to form 3-benzamido-6-nitro-N-ethylcarbazole which is then hydrogenated to form 6-amino-3-benzamido-N-ethylcarbazole. Condensation of 6-amino-3-benzamido-N-ethylcarbazole with chlroanil provides an intermediate. Cyclization of the intermediate in the presence of a cyclization reagent provides the compound of Formula-I. The pigment has wavelength of maximum absorption (λm) at 571 nm in dimethylformamide as a solvent.
摘要翻译：本公开提供式I的咔唑 - 二恶嗪颜料; 其中，R为C1-C8烷基，优选R为乙基，R1为氯基，R2为-NHC（= O）Ph基。颜料由3-硝基-N-乙基咔唑合成。第一步是硝化N-硝基-N-乙基咔唑形成3,6-二硝基-N-乙基咔唑，将其还原形成3-氨基-6-硝基-N-乙基咔唑。该氨基化合物被苯甲酰化以形成3-苯甲酰氨基-6-硝基-N-乙基咔唑，然后将其氢化形成6-氨基-3-苯甲酰氨基-N-乙基咔唑。 6-氨基-3-苯甲酰氨基-N-乙基咔唑与氯苯腈的缩合提供中间体。在环化试剂存在下中间体的环化提供了式I化合物。该颜料在作为溶剂的二甲基甲酰胺中，在571nm具有最大吸收波长（λm）。

2. 发明申请

US20110098466A1 Synthesis Of Triphenodioxazine Pigments 审中-公开
标题翻译：三苯并二恶嗪颜料的合成
公开(公告)号：US20110098466A1
公开(公告)日：2011-04-28
申请号：US12673998
申请日：2006-06-12
申请人： Peter Kempter , Wilhelm Streck
发明人： Peter Kempter , Wilhelm Streck
IPC分类号： C07D498/22
CPC分类号： C09B19/02
摘要： The invention relates to a process for the preparation of compounds of the general formula (I) where X are halogen atoms, the rings labeled A are linearly or angularly fused in position 1,2; 2,3 or 3,4, and in position 8,9; 9,10 or 10,11, to a 5- or 6-membered heterocyclic ring containing in the ring one nitrogen atom and one oxygen atom, or containing in the ring two nitrogen atoms, comprising an oxidation of a 3,6-bisarylamino-2,5-dihalobenzoquinone of the formula (II) in an aprotic-polar organic solvent in the presence of an organic sulfonic acid.
摘要翻译：本发明涉及制备通式（I）的化合物的方法，其中X是卤素原子，标记为A的环在1,2位线性或角度融合; 2,3或3,4，位置8,9; 9,10或10,11，涉及在环中含有一个氮原子和一个氧原子或在环中含有两个氮原子的5-或6-元杂环，其包含3,6-双芳基氨基 - （II）的2,5-二卤代苯醌在非质子极性有机溶剂中，在有机磺酸存在下进行。

3. 发明授权

US07737138B2 Methods of treatment of a tauopathy condition comprising the use of thioninium compounds 有权
标题翻译：包括使用硫铊化合物的tau病变病况的治疗方法
公开(公告)号：US07737138B2
公开(公告)日：2010-06-15
申请号：US11391675
申请日：2006-03-29
申请人： Claude M. Wischik , Janet E. Rickard , Charles R. Harrington , David Horsley , John M. D. Storey , Colin Marshall , James P. Sinclair , Han Wan Tan
发明人： Claude M. Wischik , Janet E. Rickard , Charles R. Harrington , David Horsley , John M. D. Storey , Colin Marshall , James P. Sinclair , Han Wan Tan
IPC分类号： A61K31/5415
CPC分类号： C09B19/02 , C07D279/18
摘要： This invention pertains generally to the field of chemical synthesis and purification, and more specifically to methods of synthesizing and purifying certain 3,7-diaminophenothiazin-5-ium compounds (referred to herein as “diaminophenothiazinium compounds”) including Methythioninium Chloride (MTC) (also known as Methylene Blue). In one embodiment, the method comprises the steps of, in order: nitrosylation (NOS); nitrosyl reduction (NR); thiosulfonic acid formation (TSAF); oxidative coupling (OC); Cr(VI) reduction (CR); isolation and purification of zwitterionic intermediate (IAPOZI); ring closure (RC); chloride salt formation (CSF); one of: sulphide treatment (ST); dimethyldithiocarbamate treatment (DT); carbonate treatment (CT); ethylenediaminetetraacetic acid treatment (EDTAT); organic extraction (OE); and recrystallisation (RX). The present invention also pertains to the resulting (high purity) compounds, compositions comprising them (e.g., tablets, capsules), and their use in methods of inactivating pathogens, and methods of medical treatment and diagnosis, etc., for example, for tauopathies, Alzheimer's disease (AD), skin cancer, melanoma, viral diseases, bacterial diseases, or protozoal diseases.
摘要翻译：本发明一般涉及化学合成和纯化领域，更具体地涉及合成和纯化某些3,7-二氨基吩噻嗪-5-肟化合物（本文中称为“二氨基吩噻嗪鎓化合物”）的方法，包括氯化铁偶氮（MTC）（也称为亚甲基蓝）。在一个实施方案中，该方法包括以下步骤：按顺序：亚硝基化（NOS）; 亚硝酰还原（NR）; 硫代磺酸形成（TSAF）; 氧化偶合（OC）; Cr（VI）还原（CR）; 两性离子中间体（IAPOZI）的分离和纯化; 闭环（RC）; 氯化物盐形成（CSF）; 一种：硫化物处理（ST）; 二甲基二硫代氨基甲酸酯处理（DT）; 碳酸盐处理（CT）; 乙二胺四乙酸处理（EDTAT）; 有机萃取（OE）; 和重结晶（RX）。本发明还涉及所得的（高纯度）化合物，包含它们的组合物（例如片剂，胶囊）及其在灭活病原体的方法中的用途，以及治疗和诊断方法等，例如对于tau蛋白病，阿尔茨海默病（AD），皮肤癌，黑素瘤，病毒性疾病，细菌性疾病或原生动物疾病。

4. 发明申请

US20080073625A1 Colored Composition for Color Filter and Display Using Color Filters Formed of the Colored Composition 审中-公开
标题翻译：彩色组合物，用于彩色滤光片和显示器，使用彩色组合物形成的彩色滤光片
公开(公告)号：US20080073625A1
公开(公告)日：2008-03-27
申请号：US11948810
申请日：2007-11-30
申请人： Kotaro ARAYA , Hiroshi SASAKI , Yasushi TOMIOKA
发明人： Kotaro ARAYA , Hiroshi SASAKI , Yasushi TOMIOKA
IPC分类号： G02B5/23
CPC分类号： C09B57/004 , C09B1/005 , C09B5/48 , C09B5/62 , C09B7/02 , C09B19/02 , C09B47/16 , C09B47/26 , C09B48/00 , C09B57/04 , C09B68/443 , G02F1/133514 , H01L27/322 , H01L51/0078 , Y10T428/10 , Y10T428/1036 , Y10T428/1041
摘要： An object of the present invention is to obtain color filters having a high contrast, a high color purity and an improved transmittance for blue color, and a display using the color filters. In the present invention, there is used a colored composition for color filter comprising at least one coloring agent, a base polymer and at least one solvent, said base polymer containing a polyamicacid whose light transmittance decreases by 2% or less in the visible region (wavelength: 400 nm to 800 nm).
摘要翻译：本发明的目的是获得具有高对比度，高色纯度和改善的蓝色透射率的滤色器以及使用滤色器的显示器。在本发明中，使用包含至少一种着色剂，基础聚合物和至少一种溶剂的滤色剂用着色组合物，所述基础聚合物含有在可见光区域的透光率降低2％以下的聚酰胺酸（波长：400nm〜800nm）。

5. 发明申请

US20070221884A1 Liminescent Silicon Oxide Flakes 审中-公开
标题翻译：发光氧化硅片
公开(公告)号：US20070221884A1
公开(公告)日：2007-09-27
申请号：US11631446
申请日：2005-07-06
申请人： Holger Hoppe , Patrice Bujard , Martin Muller , Hans Reichert
发明人： Holger Hoppe , Patrice Bujard , Martin Muller , Hans Reichert
IPC分类号： C09K11/06 , C09K11/08
CPC分类号： D06P1/0012 , A61K8/0258 , A61K8/0279 , A61K8/25 , A61K2800/434 , A61K2800/56 , A61K2800/621 , A61K2800/622 , A61K2800/623 , A61K2800/651 , A61Q1/02 , C01P2006/12 , C01P2006/16 , C03C14/004 , C08K3/36 , C08K7/26 , C08K9/04 , C09B5/62 , C09B11/02 , C09B11/08 , C09B11/24 , C09B19/00 , C09B19/02 , C09B21/00 , C09B23/0091 , C09B23/102 , C09B23/141 , C09B23/148 , C09B35/035 , C09B48/00 , C09B57/00 , C09B57/004 , C09B57/02 , C09B57/06 , C09B57/08 , C09C1/0015 , C09C1/0018 , C09C2200/1037 , C09C2210/50 , C09D7/62 , C09D7/70 , C09D11/033 , C09D11/322 , C09K11/02 , C09K11/06 , C09K11/08 , C09K11/7721 , C09K11/7734 , C09K11/7739 , C09K11/7771 , C09K11/7787 , C09K2211/1029 , C09K2211/1033 , C09K2211/1037 , C09K2211/1088 , D06L4/60 , D06P1/44 , D06P5/30 , G03G9/0902 , G03G9/09716
摘要： The present invention relates to luminescent SiOz, flakes, especially porous luminescent SiOz flakes, wherein 0.70≦z≦2.0, especially 0.95≦z≦2.0, comprising an organic, or inorganic luminescent compound, or composition, which can provide enhanced (long term) luminescent efficacy.
摘要翻译：本发明涉及发光性SiO 2薄片，特别是多孔发光SiO 2薄片，其中0.70≤z≤2.0，特别是0.95≤z≤2.0，包括可以提供增强（长期）发光功效的有机或无机发光化合物或组合物。

6. 发明申请

US20060287523A1 Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (MTC) 有权
标题翻译：二氨基吩噻嗪鎓化合物的化学合成和纯化方法，包括甲基硫堇（MTC）
公开(公告)号：US20060287523A1
公开(公告)日：2006-12-21
申请号：US11391675
申请日：2006-03-29
申请人： Claude Wischik , Janet Rickard , Charles Harrington , David Horsley , John Storey , Colin Marshall , James Sinclair , Han Tan
发明人： Claude Wischik , Janet Rickard , Charles Harrington , David Horsley , John Storey , Colin Marshall , James Sinclair , Han Tan
IPC分类号： C07D279/18
CPC分类号： C09B19/02 , C07D279/18
摘要： This invention pertains generally to the field of chemical synthesis and purification, and more specifically to methods of synthesizing and purifying certain 3,7-diaminophenothiazin-5-ium compounds (referred to herein as “diaminophenothiazinium compounds”) including Methythioninium Chloride (MTC) (also known as Methylene Blue). In one embodiment, the method comprises the steps of, in order: nitrosylation (NOS); nitrosyl reduction (NR); thiosulfonic acid formation (TSAF); oxidative coupling (OC); Cr(VI) reduction (CR); isolation and purification of zwitterionic intermediate (IAPOZI); ring closure (RC); chloride salt formation (CSF); one of: sulphide treatment (ST); dimethyldithiocarbamate treatment (DT); carbonate treatment (CT); ethylenediaminetetraacetic acid treatment (EDTAT); organic extraction (OE); and recrystallisation (RX). The present invention also pertains to the resulting (high purity) compounds, compositions comprising them (e.g., tablets, capsules), and their use in methods of inactivating pathogens, and methods of medical treatment and diagnosis, etc., for example, for tauopathies, Alzheimer's disease (AD), skin cancer, melanoma, viral diseases, bacterial diseases, or protozoal diseases.
摘要翻译：本发明一般涉及化学合成和纯化领域，更具体地涉及合成和纯化某些3,7-二氨基吩噻嗪-5-肟化合物（本文中称为“二氨基吩噻嗪鎓化合物”）的方法，包括氯化铁偶氮（MTC）（也称为亚甲基蓝）。在一个实施方案中，该方法包括以下步骤：按顺序：亚硝基化（NOS）; 亚硝酰还原（NR）; 硫代磺酸形成（TSAF）; 氧化偶合（OC）; Cr（VI）还原（CR）; 两性离子中间体（IAPOZI）的分离和纯化; 闭环（RC）; 氯化物盐形成（CSF）; 一种：硫化物处理（ST）; 二甲基二硫代氨基甲酸酯处理（DT）; 碳酸盐处理（CT）; 乙二胺四乙酸处理（EDTAT）; 有机萃取（OE）; 和重结晶（RX）。本发明还涉及所得的（高纯度）化合物，包含它们的组合物（例如片剂，胶囊）及其在灭活病原体的方法中的用途，以及治疗和诊断方法等，例如对于tau蛋白病，阿尔茨海默病（AD），皮肤癌，黑素瘤，病毒性疾病，细菌性疾病或原生动物疾病。

7. 发明授权

US06617453B1 Triphendioxazine compounds 失效
标题翻译：三苯并二恶嗪化合物
公开(公告)号：US06617453B1
公开(公告)日：2003-09-09
申请号：US09718278
申请日：2000-11-22
申请人： Bansi Lal Kaul , Patrick Boeglin , Peter Kempter
发明人： Bansi Lal Kaul , Patrick Boeglin , Peter Kempter
IPC分类号： C07D49822
CPC分类号： C07D498/22 , C09B19/02
摘要： The triphendioxazine compounds of the general formula (I) in which the rings labeled A in positions 1,2-, 2,3- or 3,4- and 8,9-, 9,10- or 10,11- carry a linearly or angularly fused heterocyclic ring containing at least one nitrogen atom which is substituted or unsubstituted, with the proviso that compounds with only unsubstituted nitrogen atoms and symmetrically disubstituted compounds with C1-2alkyl and unsubstituted phenyl substituents are excluded, are outstanding pigments and are notable over the closest comparable pigments in particular for better migration, light and solvent fastnesses, better heat stability and enhanced colouring power and also better dispersibility and capability to be brought into pigment form. The invention also relates to a process for preparing these triphendioxazine compounds which is characterized by a cyclization step conducted in the presence of manganese dioxide and concentrated sulphuric acid.
摘要翻译：通式（I）的三苯并二恶嗪化合物其中1,2-，2,3-或3,4-和8,9-，9,10-或10,11位上标记为A的环具有线性或含有至少一个被取代或未取代的氮原子的角稠合杂环，条件是不包括仅具有未取代的氮原子和具有C 1-2烷基和未被取代的苯基取代基的对称二取代化合物的化合物是优异的颜料，并且在特别是用于更好的迁移，轻和耐溶剂牢度，更好的热稳定性和增强的着色能力以及更好的分散性和能够进入颜料形式的最接近的可比颜料。本发明还涉及一种制备这些三苯并二恶嗪化合物的方法，其特征在于在二氧化锰和浓硫酸存在下进行环化步骤。

8. 发明申请

US20020091258A1 Mixed crystals of benzimidazolonedioxazine compounds 失效
标题翻译：苯并咪唑啉二恶嗪化合物的混合晶体
公开(公告)号：US20020091258A1
公开(公告)日：2002-07-11
申请号：US10001777
申请日：2001-10-24
申请人： Clariant GmbH
发明人： Martin U. Schmidt , Peter Kempter , Carsten Plueg , Roland Born
IPC分类号： C07D498/14
CPC分类号： C09B19/02 , C09B67/0034
摘要： A mixed crystal of two or more different benzimidazolonedioxazine compounds of the formula (1) 1 where X and Xnull are identical or different and are hydrogen or halogen, R1, R1null, R2 and R2null are identical or different and are hydrogen, C1-C18 alkyl, trifluoromethyl, C1-C18 alkylcarbonyl, C5-C6 cycloalkyl or phenyl which may be unsubstituted or substituted by one or more halogen atoms, nitro groups, trifluoromethyl, C1-C18 alkyl, C1-C18 alkoxy, C1-C18 alkylcarbonyl and/or C1-C18 alkoxycarbonyl groups. The mixed crystals are of low solubility and feature good fastness properties and red to blue colorations. The mixed crystals are suitable for pigmenting paints, plastics, printing inks, aqueous or solvent-based pigment preparations, electrophotographic toners and developers, powder coating materials, inks, preferably inkjet inks, color filters, and for coloring seed and cosmetics.
摘要翻译：其中X和X'相同或不同，为氢或卤素，R1，R1'，R2和R2'的两种或更多种不同的式（1）苯并咪唑并二恶嗪化合物的混合晶体是相同或不同的，它们是氢，C1- C18烷基，三氟甲基，C 1 -C 18烷基羰基，C 5 -C 6环烷基或可被未取代或被一个或多个卤素原子取代的苯基，硝基，三氟甲基，C 1 -C 18烷基，C 1 -C 18烷氧基，C 1 -C 18烷基羰基和/ 或C 1 -C 18烷氧基羰基。混合晶体的溶解度低，具有良好的牢度和红 - 蓝色。混合晶体适用于着色涂料，塑料，印刷油墨，水性或溶剂型颜料制剂，电子照相色调剂和显影剂，粉末涂料，油墨，优选喷墨油墨，滤色器，以及用于着色种子和化妆品。

9. 发明申请

US20010039358A1 Novel fluorescent pigments 失效
标题翻译：新型荧光颜料
公开(公告)号：US20010039358A1
公开(公告)日：2001-11-08
申请号：US09778324
申请日：2001-02-06
发明人： Zhimin Hao , John S. Zambounis , Abul Iqbal
IPC分类号： C07C049/675 , C07C050/18 , C07F007/02
CPC分类号： C09B68/443 , C09B1/005 , C09B5/62 , C09B7/02 , C09B19/02 , C09B29/0033 , C09B47/12 , C09B47/26 , C09B48/00 , C09B57/04 , C09B67/0077 , C09B68/46 , C09B68/4677 , C09B69/08 , C09K11/06 , G03G5/0696 , G03G9/0908 , G03G9/0912 , G03G9/0918 , G03G9/092 , G03G9/0924 , G03G9/0926
摘要： Compounds of formulaA(B)x,nullnull(I),wherein x is an integer from 1 to 4, A is the radical of a chromophore of the quinacridone, anthraquinone, perylene, indigo, quinophthalone, isoindolinone, isoindoline, dioxazine, phthalocyanine or azo series, which radical contains x N-atoms attached to B, preferably with at least one directly adjacent or conjugated carbonyl group, B is a group of formula 1 and, if x is 2, 3 or 4, may also be one, two or three hydrogen atoms. The symbols Q, R1, R2, R3, R4, X, Y, Z, m und n, are as defined in claim 1. These carbamate group-containing soluble chromophores are distinguished by outstanding solid state fluorescence in the UV range as well as the by ease with which they can be converted to the corresponding pigments in the substrate in which they are incorporated.
摘要翻译：式（1）所示的化合物，其中x为1〜4的整数，A为自由基喹吖啶酮，蒽醌，苝，靛蓝，喹酞酮，异吲哚啉酮，异吲哚啉，二恶嗪，酞菁或偶氮系列的发色团，该基团含有与B连接的x个N原子，优选与至少一个直接相邻或共轭的羰基B 是一组式，如果x是2,3或4，也可以是一个，两个或三个氢原子。符号Q，R 1，R 2，R 3，R 4，X，Y，Z，m和n如权利要求1中所定义。这些含氨基甲酸酯基团的可溶性发色团的特征在于UV范围内的突出的固态荧光，以及通过它们可以将它们转化成它们所掺入的底物中的相应颜料

10. 发明授权

US6013777A Process for the preparation of fluorescent pigments 失效
标题翻译：荧光颜料的制备方法
公开(公告)号：US6013777A
公开(公告)日：2000-01-11
申请号：US095618
申请日：1998-06-10
申请人： Zhimin Hao , John S. Zambounis , Abul Iqbal
发明人： Zhimin Hao , John S. Zambounis , Abul Iqbal
IPC分类号： C09B1/00 , C09B1/22 , C09B5/62 , C09B7/02 , C09B7/08 , C09B19/00 , C09B19/02 , C09B29/00 , C09B47/12 , C09B47/16 , C09B47/20 , C09B47/26 , C09B48/00 , C09B57/04 , C09B67/20 , C09B67/28 , C09B69/00 , C09B69/08 , C09K11/06 , G03G5/06 , G03G9/06 , G03G9/09 , C07D209/77 , C07D221/18 , C07D403/02 , C07D471/04 , C07D487/22
CPC分类号： C09B68/443 , C09B1/005 , C09B19/02 , C09B29/0033 , C09B47/12 , C09B47/26 , C09B48/00 , C09B5/62 , C09B57/04 , C09B67/0077 , C09B68/46 , C09B68/4677 , C09B69/08 , C09B7/02 , C09K11/06 , G03G9/0908 , G03G9/0912 , G03G9/0918 , G03G9/092 , G03G9/0924 , G03G9/0926 , G03G5/0696
摘要： Compounds of formulaA(B).sub.x, (I),wherein x is an integer from 1 to 4,A is the radical of a chromophore of the quinacridone, anthraquinone, perylene, indigo, quinophthalone, isoindolinone, isoindoline, dioxazine, phthalocyanine or azo series, which radical contains x N-atoms attached to B, preferably with at least one directly adjacent or conjugated carbonyl group,B is a group of formula ##STR1## and, if x is 2, 3 or 4, may also be one, two or three hydrogen atoms. The symbols Q, R.sub.1, R.sub.2, R.sub.3, R.sub.4, X, Y, Z, m and n, are as defined in claim 1.These carbamate group-containing soluble chromophores are distinguished by outstanding solid state fluorescence in the UV range as well as the by ease with which they can be converted to the corresponding pigments in the substrate in which they are incorporated.
摘要翻译：式A（B）x，（I）的化合物，其中x是1至4的整数，A是喹吖啶酮，蒽醌，苝，靛蓝，喹酞酮，异吲哚啉酮，异吲哚啉，二恶嗪，酞菁或偶氮的发色团的基团该基团包含与B连接的x个N原子，优选与至少一个直接相邻或共轭的羰基，B是式的基团，如果x是2,3或4，也可以是一个，两个或三个氢原子。符号Q，R1，R2，R3，R4，X，Y，Z，m和n如权利要求1中所定义。这些含氨基甲酸酯基团的可溶性发色团的特征在于UV范围内的优异的固态荧光，以及通过它们可以将它们转化成它们所掺入的底物中的相应颜料。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式